Article

Computational assessment of the spike protein antigenicity reveals diversity in B cell epitopes but stability in T cell epitopes across SARS-CoV-2 variants

2021-03-25

Abstract excerpt

Since its emergence into the human population at the end of 2019, SARS-CoV-2 has caused significant morbidity and mortality worldwide. Efforts to develop a protective vaccine against COVID-19 have yielded several vaccine platforms currently in distribution targeting the original SARS-CoV-2 spike protein sequence from the first cases of infection. In recent months, variants of SARS-CoV-2 have raised concerns that v...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ed51bcd8-b2fb-54e3-86a3-8b23966cea89
DOI: 10.1101/2021.03.25.437035

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Computational assessment of the spike protein antigenicity reveals diversity in B cell epitopes but stability in T cell epitopes across SARS-CoV-2 variantsDOI 10.1101/2021.03.25.437035Read

Bioinformatic analysis of B and T cell epitopes from SARS-CoV-2 Spike, Membrane and Nucleocapsid proteins as a strategy to assess possible cross-reactivity between emerging variants, including Omicron, and other human coronavirusesSemantic proximity Read

Mutations in spike protein T cell epitopes of SARS-COV-2 variants: Plausible influence on vaccine efficacy.Semantic proximity Read

SARS-CoV-2 Omicron (BA.1 and BA.2) specific novel CD8+ and CD4+ T cell epitopes targeting spike proteinSemantic proximity Read

CD8 T cell epitope generation toward the continually mutating SARS-CoV-2 spike protein in genetically diverse human population: Implications for disease control and preventionSemantic proximity Read

The influence of major S protein mutations of SARS-CoV-2 on the potential B cell epitopesSemantic proximity Read

Exploring B-cell epitope conservation and antigenicity shift in current COVID-19 variants: Analyzing spike-antibody interactions for therapeutic uses.Semantic proximity Read

Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine DevelopmentSemantic proximity Read

Antigenic evolution of SARS coronavirus 2Semantic proximity Read

SARS-CoV-2 mutations and where to find them: An <i>in silico</i> perspective of structural changes and antigenicity of the Spike proteinSemantic proximity Read

CD8 T cell epitope generation toward the continually mutating SARS-CoV-2 spike protein in genetically diverse human population: Implications for disease control and prevention.Semantic proximity Read

Design of T cell epitope-based vaccine candidate for SARS-CoV-2 targeting nucleocapsid and spike protein escape variantsSemantic proximity Read

What makes SARS‐CoV‐2 unique? Focusing on the spike proteinSemantic proximity Read